CELGENE CORP

SUMMIT, NJ How do I update this listing?

Celgene Corp is based out of Summit. Celgene is a biopharmaceutical company, engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. Co.'s commercial stage products include: REVLIMID����, for the treatment in combination with dexamethasone for multiple myeloma patients; THALOMID����, for the treatment of patients with newly diagnosed multiple myeloma and for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum, and as maintenance therapy for prevention of the cutaneous manifestation recurrence; and VIDAZA����, that reverse the effects of deoxyribonucleic acid hypermethylation and promote gene re-expression.Whalewisdom has at least 32 13D filings, 12 13G filings, and 473 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Create Alert
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
JUNO THERAPEUTICS INC (JUNO) HEALTH CARE 11,109,160 966,052,553.60 1 13D 2018-03-02
Acceleron Pharma Inc (XLRN) HEALTH CARE 6,863,664 772,368,109.92 2 13D 2019-01-18
CRISPR Therapeutics AG (CRSP) HEALTH CARE 2,800,772 234,256,570.08 3 13D 2018-02-07
Adynxx Inc (ADYX) HEALTH CARE 150,450 45,577,234.75 4 13D 2017-06-23
Ideaya Biosciences Inc (IDYA) HEALTH CARE 1,633,263 20,513,783.28 5 13G 2019-05-28
Sutro Biopharma Inc (STRO) HEALTH CARE 1,726,207 17,348,380.35 6 13G 2018-12-31
OncoMed Pharmaceuticals Inc (OMED) HEALTH CARE 2,970,598 3,089,421.92 7 13G 2016-08-23
Tengion Inc (TNGN) HEALTH CARE 994 49.70 8 13G 2014-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments